Navigation Links
DNASequencing.com and a Portfolio of 318 'Genetic' Domain Names to be Auctioned Off at Epik.com Domain Development Conference
Date:9/14/2010

SEATTLE, Sept. 14 /PRNewswire/ -- Epik.com, a leading domain name development company, will release a list of DNA and Genetic developed domain names to be auctioned off on September 16, at 1:30 pm at the Bell Harbor Conference Center Bay Auditorium in Seattle. The domain auction is part of the inaugural Epik.com Domain Developers Conference being held September 15 – 17.  The live auction event is open to the public.

The auction lot contains the premium domain name and website www.DNASequencing.com, as well as an additional 318 DNA and genetics-related informational domain names. Scientists believe DNA sequencing will revolutionize preventative medicine, as knowing the genetic blueprints of an individual will reveal predispositions for specific conditions and diseases such as cancer, diabetes, addiction, etc and lead to 'personalized medicine'.

"Owning a massive amount of Internet Real Estate associated with DNA Sequencing, genetic mapping and personalized medicine can be a windfall for a biotechnology company that wants to control the space and capture the associated Internet search traffic," says Rob Monster, Chairman and CEO of Epik.com. "Companies like Illumina, Complete Genomics, Pacific Biosystems, IBM, Agilent, Alpha Biolab, Ambrygen, Biobasic, Elimbio, Genewiz, Genscript, Ion Torrent, Mpbio, Laragen, Sequenom, Sequetech, Seqwright, etc. could effectively control the marketplace overnight by owning these domains," said Monster.

The auction lot will feature such domains as DNAsequencing.com, DNAsequence.com, DNAmap.com, DNAcode.com, DNAlaboratory.com, GenomeCode.com, GenomeCodes.com, GeneticDoctor.com, GeneticLab.com, GeneticEngineer.com, GeneticTechnology.com and more.

Interested parties can participate in the live auction in-person or online through a real-time Internet interface. Those wanting to submit a proxy bid for the domain and website auction can contact Epik.com directly for more information and instructions. The auction is managed by Moniker® (www.moniker.com) and SnapNames® (www.snapnames.com), both Oversee.net® companies and providers of domain name registration, management, monetization, and brokerage services. Bidders can follow the auction live and, bid online or in person. Conference details can be found at: http://www.Epik.com/conf.

About Epik.com

Epik.com was founded in 2009 with a simple goal – to help domain investors evolve from a singular dependence on domain parking to a more diversified array of value creation strategies that unlock the potential associated with an intuitive domain name. Epik.com is based in Seattle and is a leading provider of managed solutions for domain investing serving the needs of individuals and institutions that seek exposure to the domain name asset class.

http://www.Epik.com

http://www.Twitter.com/EpikDotCom

http://www.Facebook.com/EpikDotCom

http://www.YouTube.com/watch?v=Z2HwPgmcvEM


'/>"/>
SOURCE Epik.com
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Shire Proposes to Expand Specialist Gastrointestinal Portfolio
2. MacroGenics Receives NIH Grant Funding of $9.8M for Three Projects; Funding Further Advances DART Platform and Infectious Disease Portfolio
3. Silence Therapeutics Expands RNAi Structural Modification IP Portfolio With Issuance of New U.S. Patent
4. QIAGEN Acquires Comprehensive Portfolio of Molecular Food Safety Tests
5. Regado Biosciences, Inc. Continues to Expand Its Patent Portfolio By Announcing Issuance of a New Patent for Its Product Candidates, the REG1 and REG2 Anticoagulation Systems
6. Mendel Announces US Miscanthus Field Trial Results: Second Year Data Demonstrate High-Yielding, Genetically Diverse Product Portfolio
7. Shires Replenished Portfolio Drives Excellent Quarterly Performance
8. Pepscan Signs Partnering Agreement With Immunovo for its Therapeutic Vaccine Portfolio
9. ClearTrial to Demonstrate How a Top 20 Sponsor Achieved -1 Percent Cost Variance Across Their $130M Clinical Portfolio at Major Industry Conference
10. EUCODIS Bioscience Receives EUR 2 Million Cash Injection to Enlarge Product Portfolio and Develop International Markets
11. New Industry Research Identifies "Operational Gap" in Clinical Trial Portfolio Management
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June, 23, 2016  The Biodesign Challenge ... envision new ways to harness living systems and biotechnology, ... Art (MoMA) in New York City ... 130 participating students, showcased projects at MoMA,s Celeste Bartos ... Paola Antonelli , MoMA,s senior curator of architecture and ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... STACS DNA ... Technical Leader at the Arkansas State Crime Laboratory, has joined STACS DNA as a ... STACS DNA team,” said Jocelyn Tremblay, President and COO of STACS DNA. “In further ...
(Date:6/23/2016)... 23, 2016  Blueprint Bio, a company dedicated to ... medical community, has closed its Series A funding round, ... "We have received a commitment from Forentis ... need to meet our current goals," stated Matthew ... runway to complete validation on the current projects in ...
(Date:6/23/2016)... CA (PRWEB) , ... June 23, 2016 , ... ... software, is exhibiting at the Pennsylvania Convention Center and will showcase its product’s ... conference. ClinCapture will also be presenting a scientific poster on Disrupting Clinical Trials ...
Breaking Biology Technology:
(Date:4/19/2016)... April 20, 2016 The new ... a compact web-based "all-in-one" system solution for all door ... reader or the door interface with integration authorization management ... control systems. The minimal dimensions of the access control ... the building installations offer considerable freedom of design with ...
(Date:4/14/2016)... , April 14, 2016 ... Malware Detection, today announced the appointment of Eyal ... new role. Goldwerger,s leadership appointment comes at ... heels of the deployment of its platform at several ... biometric technology, which discerns unique cognitive and physiological factors, ...
(Date:3/31/2016)... , March 31, 2016  Genomics firm Nabsys ... founding CEO, Barrett Bready , M.D., who returned ... of the original technical leadership team, including Chief Technology ... of Product Development, Steve Nurnberg and Vice President of ... to the company. Dr. Bready served as ...
Breaking Biology News(10 mins):